Posttranslational modifications represent a key step in modulating programmed death-1 (PD-1) functions, but the underlying mechanisms remain incompletely defined. Here, we report crosstalk between deglycosylation and ubiquitination in regulating PD-1 stability. We show that the removal of N-linked glycosylation is a prerequisite for efficient PD-1 ubiquitination and degradation. Murine double minute 2 (MDM2) is identified as an E3 ligase of deglycosylated PD-1. In addition, the presence of MDM2 facilitates glycosylated PD-1 interaction with glycosidase NGLY1 and promotes subsequent NGLY1-catalyzed PD-1 deglycosylation. Functionally, we demonstrate that the absence of T cell-specific MDM2 accelerates tumor growth by primarily upregulating PD-1. By stimulating the p53-MDM2 axis, interferon-α (IFN-α) reduces PD-1 levels in T cells, which, in turn, exhibit a synergistic effect on tumor suppression by sensitizing anti-PD-1 immunotherapy. Our study reveals that MDM2 directs PD-1 degradation via a deglycosylation-ubiquitination coupled mechanism and sheds light on a promising strategy to boost cancer immunotherapy by targeting the T cell-specific MDM2-PD-1 regulatory axis.
Pubmed ID: 37379210 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This polyclonal targets Cleaved Caspase-3 (Asp175)
View all literature mentionsThis monoclonal targets Ki-67
View all literature mentionsThis recombinant monoclonal targets CD8
View all literature mentionsThis monoclonal targets FOXP3
View all literature mentionsThis monoclonal targets Granzyme B
View all literature mentionsThis monoclonal targets Granzyme B
View all literature mentionsThis monoclonal targets TNF alpha
View all literature mentionsThis monoclonal targets IFN gamma
View all literature mentionsThis monoclonal targets CD279
View all literature mentionsThis monoclonal targets CD45
View all literature mentionsThis monoclonal targets CD44
View all literature mentionsThis monoclonal targets CD25
View all literature mentionsThis monoclonal targets CD8a
View all literature mentionsThis monoclonal targets CD4
View all literature mentionsThis monoclonal targets TCF11/NRF1 (D5B10) Rabbit mAb
View all literature mentionsThis monoclonal targets Beta Actin
View all literature mentionsThis monoclonal targets Ubiquitinylated proteins
View all literature mentionsThis polyclonal targets NGLY1
View all literature mentionsThis polyclonal targets NGLY1
View all literature mentionsThis monoclonal targets Vinculin antibody produced in mouse
View all literature mentionsThis monoclonal targets HA
View all literature mentionsThis polyclonal targets DDDDK-Tag (ECS/Enterokinase Cleavage Site)
View all literature mentionsThis monoclonal targets LC3B (D11) XP Rabbit mAb
View all literature mentionsThis monoclonal targets MDM2
View all literature mentionsThis monoclonal targets detection of MDM2, MDM2 p60 cleavage product and p53-MDM2 complexes
View all literature mentionsThis monoclonal targets CD8α
View all literature mentionsThis monoclonal targets PD-1 (CD279)
View all literature mentionsThis monoclonal targets PD-1
View all literature mentionsThis monoclonal targets CD279 (PD-1)
View all literature mentionsThis monoclonal targets PD-1
View all literature mentionsMus musculus with name STOCK Mdm2tm2.1Glo/J from IMSR.
View all literature mentions